Vyome Holdings (HIND) EBT Margin Growth (3y) (2018 - 2026)
Vyome Holdings (HIND) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -484.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 132.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 6,685.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2,054.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8,006.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 9,980.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -9,922.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,363.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -5,319.00 |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | -305,757.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -357,531.00 |
| Mar 31, 2026 | -391,815.00 |
| Dec 31, 2025 | -325,737.00 |
| Sep 30, 2025 | -2.44 Mn |
| Jun 30, 2025 | 11,513.00 |
| Mar 31, 2025 | 107,714.00 |
| Sep 30, 2024 | -140,044.00 |
| Jun 30, 2024 | 2,900.00 |
| Mar 31, 2024 | 3,845.00 |
| Dec 31, 2023 | 18,434.00 |
| Sep 30, 2023 | -1,899.00 |
| Jun 30, 2023 | 5,990.00 |
| Mar 31, 2023 | 52,665.00 |
| Dec 31, 2022 | 6,552.00 |
| Sep 30, 2022 | 125,083.00 |
| Jun 30, 2022 | 160,526.00 |
| Mar 31, 2022 | 13,653.00 |
| Sep 30, 2021 | -20,192.00 |
| Jun 30, 2021 | 26,907.00 |
| Mar 31, 2021 | 91,453.00 |